These are some of the VC and other sites we track to keep an eye on new investments and new technologies in order to identify formation of new medtech companies.
Wednesday, March 29, 2006
Tuesday, March 21, 2006
Startups Redux
In my previous post, I went generous and added the startups I planned to include in our March publication. I hav subsequently realized I was being too generous, as I keep finding out that many people in the medical product industry are clamoring for new technology/ideas, but (partly because of the interest) the small medical technology companies are increasingly inclined toward stealth. SOOO, it behooves me to try to recoup the costs I have incurrent in my hard-earned effort at ferretting out these little company gems. So, I've published a compilation of the startups I have identified who have been founded from January 2005 to March 2006.
As good readers of this blog (sigh), I will be more than happy to reward you with occasional free listings of those companies.
See the new Startup report/listing described here.
As good readers of this blog (sigh), I will be more than happy to reward you with occasional free listings of those companies.
See the new Startup report/listing described here.
Wednesday, March 15, 2006
Some new startups (wink)
Normally, I would not do this (add subscription content to this blog), but I thought I would drop a list of some new companies (from my Startups table in MedMarkets that I publish every month). Here are the ones from the upcoming March issue. For reference, my goal is to find companies that have been founded in the past month (not when they say they were founded, but when their corporate filings were done -- a harsher measure of how "new" they are). Sometimes I'll go a little farther back and publish on companies who have done an exceptional job at staying in stealth mode, but who have suddenly become apparent to me. If they are new to me (I am constantly looking), then maybe my customers haven't heard of them either.
| Company | Principal | Location | Product/Technology | Founded |
| Aragon Surgical, Inc. | Onset Ventures | Palo Alto, CA | Surgical device platform designed to reduce OR time | 2005 |
| EpiTeK, Inc. | Jean Paul Rasschaert | Pittsburgh, PA | Minimally invasive device to prevent strokes in atrial fibrillation | 2004 |
| i25tech, Inc. | John Dunning, President | Santa Fe, NM | Undisclosed device for treatment of a variety of diseases | 2005 |
| Keramed, Inc. | Yichieh Shiuey | Cupertino, CA | Device for facilitating corneal transplantation | 2005 |
| Oringen, LLC | John Krusinski, President & CEO | Tallmadge, OH | Liquid crystal sensor for bacteria and viruses | 2006 |
| Transtimulation Research, Inc. | Jiande Chen | Oklahoma City, OK | Intestinal pacing for obesity | 2005 |
Aragon Surgical, LLC — Palo Alto, CA; no URL
EpiTeK, Inc. —
i25Tech, Inc. —
Keramed, Inc. —
Oringen, LLC — Tallmadge, OH; no URL
Transtimulation Research Inc. —
Thursday, March 09, 2006
Cartilage paste, devices, commerce and optimism
In the healthcare arena, I keep finding it amazing how so many technologies that are different in so many ways are changing the definitions of what constitutes a medical device. I came across this article on cartilage paste in March issue of Arthroscopy: Journal of Arthroscopy–Related Surgery. Now, while this is not a new technology, it does represent the kind of marriage of technologies that happens frequently these days in the medical field. I then came across details of a Tallmadge, OH, company called Oringen, which has licensed a technology (from Northeastern Ohio Universities College of Medicine and Kent State University) to be developed into a liquid crystal sensor for detection of
bacteria and viruses (Pathogen Detection Systems of Boulder, Colorado, has also licensed the technology).
I am not an obligatory cheerleader for technology, because I really do believe that in the U.S. we have spent far too much on healthcare without it producing the intended or necessary improvements in quality of life. Too frequently, "innovations" have just resulted in higher premiums for us all. However, when you consider the steady progression of materials technologies, nanotechnologies, cell/tissue engineering technologies, the development of drug/device hybrids and other technologies, it becomes difficult to imagine a clinical problem that isn't destined to be solved by medical technology. This may be wildly optimistic and ignore the lessons of history, but this sense of optimism is the driving force (that, and its associated commercial success!) behind the great diversity of medical technologies being pursued in different applications.
bacteria and viruses (Pathogen Detection Systems of Boulder, Colorado, has also licensed the technology).I am not an obligatory cheerleader for technology, because I really do believe that in the U.S. we have spent far too much on healthcare without it producing the intended or necessary improvements in quality of life. Too frequently, "innovations" have just resulted in higher premiums for us all. However, when you consider the steady progression of materials technologies, nanotechnologies, cell/tissue engineering technologies, the development of drug/device hybrids and other technologies, it becomes difficult to imagine a clinical problem that isn't destined to be solved by medical technology. This may be wildly optimistic and ignore the lessons of history, but this sense of optimism is the driving force (that, and its associated commercial success!) behind the great diversity of medical technologies being pursued in different applications.
Subscribe to:
Posts (Atom)
